HDAC9 and early-onset autosomal dominant Alzheimer disease: In regard to Alzheimer's disease, HDAC inhibitors exhibit various beneficial effects in mouse models of AD, such as APP/PS1 mouse models of familial AD [115, 116], and the CK-p25 mouse model of AD-related neurodegeneration and memory decline [109].